# International Tower Hill Mines Ltd: financial statements, quarterly

THM · NYSE · CIK 1134115 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/thm.md) · [Financials](/companies/thm/financials.md) · [Filings](/companies/thm/filings.md) · [Insiders](/companies/thm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/thm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cost of revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(710)](/filings/0001410578-24-001791.md) | [(716) d](/filings/0001410578-25-000319.md) | [(545)](/filings/0001410578-25-001126.md) | [(1,432)](/filings/0001410578-25-001650.md) | [(667)](/filings/0001104659-25-108150.md) | [(955) d](/filings/0001104659-26-026416.md) | [(669)](/filings/0001104659-26-057981.md) | [(1,925)](/filings/0001104659-26-094923.md) | [(732)](/filings/0001104659-25-108150.md) | [(1,312) d](/filings/0001104659-26-026416.md) | [2,274](/filings/0001104659-26-057981.md) | [(3,384)](/filings/0001104659-26-094923.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001410578-24-001791.md) | not reported | [0.00](/filings/0001410578-25-001126.md) | [(0.01)](/filings/0001410578-25-001650.md) | [0.00](/filings/0001104659-25-108150.md) | not reported | [0.00](/filings/0001104659-26-057981.md) | [(0.01)](/filings/0001104659-26-094923.md) | [0.00](/filings/0001104659-25-108150.md) | not reported | [0.01](/filings/0001104659-26-057981.md) | [(0.01)](/filings/0001104659-26-094923.md) |
| Basic EPS | $ per share | [0.00](/filings/0001410578-24-001791.md) | not reported | [0.00](/filings/0001410578-25-001126.md) | [(0.01)](/filings/0001410578-25-001650.md) | [0.00](/filings/0001104659-25-108150.md) | not reported | [0.00](/filings/0001104659-26-057981.md) | [(0.01)](/filings/0001104659-26-094923.md) | [0.00](/filings/0001104659-25-108150.md) | not reported | [0.01](/filings/0001104659-26-057981.md) | [(0.01)](/filings/0001104659-26-094923.md) |

- Cost of revenue: not reported
- Operating income: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.4](/filings/0001410578-23-002231.md) | [1.7](/filings/0001410578-25-000319.md) | [2.6](/filings/0001410578-24-000716.md) | [2.3](/filings/0001410578-24-001257.md) | [1.7](/filings/0001410578-24-001791.md) | [1.0](/filings/0001104659-25-108150.md) | [4.3](/filings/0001410578-25-001126.md) | [2.8](/filings/0001410578-25-001650.md) | [2.3](/filings/0001104659-25-108150.md) | [1.4](/filings/0001104659-26-094923.md) | [64.7](/filings/0001104659-26-057981.md) | [60.4](/filings/0001104659-26-094923.md) |
| Current assets | $m | [2.6](/filings/0001410578-23-002231.md) | [2.0](/filings/0001410578-25-000319.md) | [3.8](/filings/0001410578-24-000716.md) | [2.5](/filings/0001410578-24-001257.md) | [1.9](/filings/0001410578-24-001791.md) | [1.1](/filings/0001104659-26-026416.md) | [4.4](/filings/0001410578-25-001126.md) | [3.1](/filings/0001410578-25-001650.md) | [2.5](/filings/0001104659-25-108150.md) | [1.5](/filings/0001104659-26-094923.md) | [115](/filings/0001104659-26-057981.md) | [113](/filings/0001104659-26-094923.md) |
| Total assets | $m | [57.9](/filings/0001410578-23-002231.md) | [57.4](/filings/0001410578-25-000319.md) | [59.2](/filings/0001410578-24-000716.md) | [57.9](/filings/0001410578-24-001257.md) | [57.3](/filings/0001410578-24-001791.md) | [56.5](/filings/0001104659-26-026416.md) | [59.8](/filings/0001410578-25-001126.md) | [58.5](/filings/0001410578-25-001650.md) | [57.9](/filings/0001104659-25-108150.md) | [56.9](/filings/0001104659-26-094923.md) | [171](/filings/0001104659-26-057981.md) | [168](/filings/0001104659-26-094923.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [0.2](/filings/0001410578-23-002231.md) | [0.2](/filings/0001410578-25-000319.md) | [0.3](/filings/0001410578-24-000716.md) | [0.2](/filings/0001410578-24-001257.md) | [0.2](/filings/0001410578-24-001791.md) | [0.2](/filings/0001104659-26-026416.md) | [0.2](/filings/0001410578-25-001126.md) | [0.2](/filings/0001410578-25-001650.md) | [0.3](/filings/0001104659-25-108150.md) | [0.5](/filings/0001104659-26-094923.md) | [0.5](/filings/0001104659-26-057981.md) | [2.4](/filings/0001104659-26-094923.md) |
| Shareholders' equity | $m | [57.8](/filings/0001410578-24-001791.md) | [57.1](/filings/0001104659-26-026416.md) | [58.9](/filings/0001410578-25-001650.md) | [57.8](/filings/0001104659-25-108150.md) | [57.1](/filings/0001104659-25-108150.md) | [56.3](/filings/0001104659-26-094923.md) | [59.6](/filings/0001104659-26-094923.md) | [58.3](/filings/0001104659-26-094923.md) | [57.6](/filings/0001104659-25-108150.md) | [56.4](/filings/0001104659-26-094923.md) | [170](/filings/0001104659-26-094923.md) | [166](/filings/0001104659-26-094923.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(535) d](/filings/0001410578-24-001791.md) | [(736) d](/filings/0001410578-25-000319.md) | [(454)](/filings/0001410578-25-001126.md) | [(1,202) d](/filings/0001410578-25-001650.md) | [(546) d](/filings/0001104659-25-108150.md) | [(692) d](/filings/0001104659-26-026416.md) | [(660)](/filings/0001104659-26-057981.md) | [(1,514) d](/filings/0001104659-26-094923.md) | [(523) d](/filings/0001104659-25-108150.md) | [(935) d](/filings/0001104659-26-026416.md) | [1,808](/filings/0001104659-26-057981.md) | [(2,067) d](/filings/0001104659-26-094923.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [195](/filings/0001410578-23-002231.md) | [195](/filings/0001410578-24-000716.md) | [195](/filings/0001410578-24-001257.md) | [196](/filings/0001410578-24-001791.md) | [199](/filings/0001410578-25-001126.md) | [200](/filings/0001410578-25-001650.md) | [200](/filings/0001104659-25-108150.md) | [203](/filings/0001104659-26-057981.md) | [208](/filings/0001104659-26-094923.md) | [208](/filings/0001104659-25-108150.md) | [248](/filings/0001104659-26-057981.md) | [262](/filings/0001104659-26-094923.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 195,885,531 at 2033-10-31, from the cover of the [10-Q filed 2023-11-08](/filings/0001410578-23-002231.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.